Iridex Corp Stock Prediction
AI-powered sentiment analysis and prediction trends for IRIX, updated each market day.
IRIX AI Sentiment
AI sees no strong directional signal for Iridex Corp stock over the next 10 market days.
Prediction date: April 30, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Iridex Corp
IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
Sector
Exchange
Market Cap
$18,172,771
Cap Tier
Employees
108
Headquarters
MOUNTAIN VIEW, CA
Listed Since
Feb. 16, 1996
Website
IRIX Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
IRIX Volatility
Iridex Corp has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
